Overcoming challenges in noninvasive diabetes management through wearable devices

Diabetes is an increasingly pervasive disease, currently affecting over 500 million adults worldwide. Since there is as yet no cure for type 1 or type 2 diabetes, patients must regularly monitor their BGLs to keep them in check.

Formycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences – Biotech Investments

EQS-News: Formycon AG / Key word(s): 9 Month figures/Conference Formycon invites to earnings call on the nine-month results 2024 and announces participation in international investor

November 20, 2024

J&J cuts the price of its lifesaving TB pill by more than half for many low- and middle-income countries

Amid controversy over access to a lifesaving tuberculosis pill, a new contracting effort is expected to lower the price for the medicine by as much

August 30, 2023

Cross-species liver cell growth could represent a solution to transplant shortage

Liver disease, due to viral infections, alcohol abuse, obesity, or cancer, accounts for 1 in every 25 deaths worldwide.

May 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.